Beruflich Dokumente
Kultur Dokumente
A. PATIENT IDENTITY
Name : Mr. AS
Gender : Male
MR : 640440
B. ANAMNESIS
Experienced since 2 months ago and was advancing 1 last week. Shortness of breath
experienced by suddenly without being influenced activity. Shortness of breath positive history.
history 4 times treated in RSWS with swelling of the heart. no chest pain, no history of chest
pain. Patients admitted to a comfortable bed with plenty of pillows
C. PHYSICAL EXAMINATION
General Status
Moderate illness/ Well nourished/ Compos mentis
Nutritional Status:
Weight : 50 kg
Height : 163 cm
BMI : 18,80 kg/m2 (normal)
Vital Sign
Blood Pressure : 120/70 mmHg
Pulse Rate : 105 bpm
Respiratory Rate : 28 bpm
Temperature : 36.6 0C (axilla)
Thorax Examination
Inspection : Symmetric between left and right chest.
Palpation : No mass, no tenderness.
Percussion : Sonor between left and right chest, lung-liver border in ICS VI right
anterior.
Auscultation:
Respiratory sound: Vesicular
Additional sound : Ronchi (+/+) in the median basal lung, Wheezing -/-
Heart examination :
Inspection : Apex invisible
Palpation : Apex impalpable
Percussion :
Upper heart : ICS II parasternalis linea sinistra
Bottom heart : ICS V parasternalis linea dextra
Left Heart : ICS V midclavicularis linea sinistra
Right heart : ICS IV parasternalis linea dextra
Auscultation : heart sounds I/II regular, murmur (+) in VRSB and apex (systolic),
gallop (-)
Abdomen Examination :
Inspection : flat, following breath movement
Auscultation : peristaltic sound (+), normal
Palpation : mass (-), pain (-), liver and lien impalpable
Percussion : tymphani (+), ascites (-)
Extremities Examination :
Oedema Pretibial -/-
Oedema dorsum pedis +/+
D. SUPPORTING EXAMINATION
LABORATORY FINDING
September 12th 2015 (1st day of treatment)
Ureum 71 10-50
Troponin T <0,05
CK 202 <190
CKMB 38 <25
HCT 50,9% 37 48
PT 26,1 10 14
INR 2,49
ELECTROCARDIOGRAM (September 12th 2015 (1st day of treatment)
ECG INTERPRETATION
Interpretasi
Ritme : Asinus
Heart Rate : 127 bpm
Axis : 45o (Left Axis Deviation)
Regularity : irreguler
P wave : can not be assessed
PR Interval : can not be assessed
QRS complex : poor R wave progression, QRS duration 0,08 detik
ST Segment : in the normal range
T wave : inverted in lead AVL and V5
Conclusion : Atrial fibrillation with a ventricular rate of 127 beats / min (Rapid
Ventricular Response), left axis deviation without ventricular enlargement
E. DIAGNOSIS
CHF NYHA III
Atrial Fibrilasi
MR, AR moderate
F. MANAGEMENT
O2 4 lpm via nasal canule
IVFD NacL 0,9 % 500 cc/24 hours
Furosemide 40 mg/24 hours/IV
Simvastatin 40 mg/24 hours/oral
Digoksin 0,25 mg/24 hours/IV
Warfarin 1 mg/24 hours/oral
Atrial Fibrillation
A. Definition
B. Classification
According to the AHA (American Heart Association), the classification of atrial
fibrillation can be divided into 4 types, that is:
C. Etiology
Etiology associated with AF is divided into several factors, including that is:
a. Increased pressure / resistance atrium
1. Valvular heart disease
2. Abnormalities charging and discharging atrium space
3. cardiac hypertrophy
4. cardiomyopathy
5. pulmonary hypertension (chronic obstructive pulmonary disease and chronic
pulmonary cast)
6. Tumor intracardiac
b. Infiltrative and inflammatory processes
1. pericarditis / miocarditis
2. Amyloidosis and sarcoidosis
3. Factors increasing age
c. The infection process
1. Fever and all kinds of infections
d. Endocrine disorders
1. Hyperthyroidism
2. Pheochromocytoma
e. neurogenic
1. Stroke
2. subarachnoid hemorrhage
f. ischemic Atrium
1. Infarction miocardial
g. Drugs
1. Alcohol
2. Caffeine
h. Heredity / genetic
Basically AF, does not provide the typical signs and symptoms in the course of their
illness. Generally, symptoms of AF are increased heart rate, heart rhythm irregularity and
hemodynamic instability. Besides that, AF also provide other symptoms caused by a decrease in
blood oxygenation to the tissues, such as dizziness, weakness, fatigue, shortness of breath and
chest pain. However, more than 90% of AF episodes do not cause symptoms.
E. Risk factor
a. Diabetes mellitus
b. Hypertension
e. Thyroid disease
h. Age 60 years
i. Life Style
F. Pathophysiology
AF mechanism consists of two processes, namely the processes of local activation and
multiple wavelet reentry. Local activation process can involve a single depolarization processes
or repetitive depolarization. At the local activation process, the dominant ectopic focus is derived
from the superior pulmonary veins. In addition, the ectopic focus could also come from the right
atrium, superior vena cava and sinus coronarius. This raises the ectopic focus electrical signals
that influence the action potential in the atrium and potentially interfere with the action initiated
by the SA node.
While multiple wavelet reentry, an action potential repetitive process and involves the
circuit / track depolarization. Multiple wavelet reentry mechanism does not depend on the
existence of such an ectopic focus on local activation process, but more or less depending on the
electrical signals that affect depolarization. In the multiple wavelet reentry, a little amount of
electrical signal is influenced by three factors, namely the refractory period, the amount of space
atrium and conduction velocity. This can be analogous to that in atrial enlargement will usually
be accompanied by a shortening of the refractory period and a decrease in conduction velocity.
The third factor is exactly what will improve the electrical signals and cause an increase in
depolarization and trigger the occurrence of AF.
Figure 2. A. Local Activation Process B. Process Atrial Fibrillation and Atrial
Fibrillation Multiple Reentry Wavelets
G. Management
1. Warfarin
Warfarin is an anticoagulant drug class include that function in the process of formation
of fibrin blockage to reduce or prevent coagulation. Warfarin is given orally and is very rapidly
absorbed reaching peak plasma concentrations within 1 hour with 100% bioavailability.
Warfarin in metabolism by oxidation (L shape) and reduction (form D), followed by conjugation
glukoronidasi with working long 40 hours.
2. Aspirin
Aspirin is irreversible disabling of platelet cyclo-oxygenase (COX2) by means of
acetylation of the terminal amino acid serine. The effect of this is to inhibit the production of
COX2 endoperoksida and thromboxane (TXA2) in platelets. This is why no formation of platelet
aggregation. However, the use of aspirin for long periods can lead to a reduction in circulating
levels of blood clotting factors, especially factors II, VII, IX and X.
There are 3 types of drugs that can be used to lower increased heart rate, ie the drug
digitalis, -blockers and calcium antagonists. These drugs can be used individually or in
combination.
1. Digitalis
This drug is used to improve cardiac contractility and decrease heart rate. This makes the
performance of the heart becomes more efficient. In addition, digitalis also slow the abnormal
electrical signals from the atria to the ventricles. This results in increased ventricular filling of
abnormal atrial contraction.
2. -blockers
-blocker drug is a drug that inhibits the effects of the sympathetic nervous system.
Cardiac sympathetic nerves at work to increase the heart rate and cardiac contractility. This
effect will result in the efficiency of cardiac performance.
3. Calcium Antagonists
Calcium antagonist drugs cause a decrease in cardiac contractility due to the denial of
Ca2 + from the extracellular to the intracellular Ca2 + channel passes contained in the cell
membrane.
Cardioversion is one that can be done for the treatment of cardiac rhythm menteraturkan.
According to the understanding, cardioversion itself is a governance that serves to control the
rhythm irregularity and lowers the heart rate. Basically cardioversion is divided into two, namely
pharmacological treatment (Pharmacological Cardioversion) and electrical treatment (Electrical
cardioversion).
1. Pharmacological Cardioversion (anti-arrhythmia)
a. Amiodarone
b. Dofetilide
c. Flecainide
d. Ibutilide
e. Propafenone
f. Quinidine
2. Electrical cardioversion
A technique providing electrical current to the heart through two metal plates (pads) are
placed on the chest. The function of the electrical therapy is to restore the heart rhythm back to
normal or in accordance with NSR (node sinus rhythm).
3. Operative
a. Catheter ablation This procedure uses a surgical technique membuatan incision in the thigh
area. Then the catheter is inserted into a blood vessel up into the heart UTMA. At the end there is
an electrode catheter that functions destroy ectopic focus that is responsible for the occurrence of
AF.
b. Maze operation Maze procedure is almost the same operation with catheter ablation, but the
maze operation, will result in a "maze" that serve to help menormalitaskan conduction system
sinus SA.
c. Artificial pacemaker Artificial pacemaker is a pacemaker that is placed in the heart, which
controls the rhythm and heart rate.
H. Discussion
Tachycardia supravenrikuler not only AF, but include Atium extrasystoles, atrial flutter,
and supraventricular tachycardia. At AF, the mechanism through two processes, namely the local
activation or multiple wavelets reentry. At the local activation is predominantly due to an ectopic
focus on superior pulmonary vein, while the reentry of multiple wavelets are more likely to be
caused by atrial enlargement, shortening of the refractory period and a decrease in conduction
velocity. In addition, there are actually other factors that influence the occurrence of AF, the
heart rate of premature, autonomic nervous activity, atrial ischemia, conduction anisotropic and
increasing age.
The effect of the occurrence of AF in addition to irregularities in heart rate and increased
heart rate, thromboembolism is also a harmful effect on the heart as a result of AF.
Thromboembolism occurs as a result of three factors, namely static, endothelial dysfunction and
hypercoagulable. This mechanism occurs from static and blood endothelial damage due to
contraction and blood flow is not perfect. Besides the hypercoagulable improve the process of
blood clot that forms part of the cause of thromboembolism.